Joseph P. Lyssikatos

Companies

• Enliven Therapeutics, Inc.Chief Scientific Officer Feb 27, 2023 to now¹
• Enliven Therapeutics, Inc.Board member Feb 27, 2023 to May 31, 2024¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• ETEnliven Therapeutics, Inc. ELVN758,938 shares²$29.1M at $38.33Feb 17, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Feb 12, 2026Granted 18,750 shares of Enliven Therapeutics, Inc.²
• Feb 6, 2026Sold 5,000 shares at $29.04 of Enliven Therapeutics, Inc.³
• Jan 20, 2026Sold 14,509 shares at $26.90 of Enliven Therapeutics, Inc.⁴
• Jan 20, 2026Sold 5,491 shares at $26.37 of Enliven Therapeutics, Inc.⁴
• Jan 9, 2026Sold 50,000 shares at $29.13 of Enliven Therapeutics, Inc.⁵
• Jan 9, 2026Sold 41,198 shares at $24.90 of Enliven Therapeutics, Inc.⁵
• Jan 8, 2026Sold 33,802 shares at $24.92 of Enliven Therapeutics, Inc.⁵
• Jan 8, 2026Sold 7,500 shares at $20.13 of Enliven Therapeutics, Inc.⁵
• Dec 19, 2025Sold 5,000 shares at $16.84 of Enliven Therapeutics, Inc.⁶
• Nov 19, 2025Sold 492 shares at $23.09 of Enliven Therapeutics, Inc.⁷
• Nov 19, 2025Sold 12,008 shares at $22.30 of Enliven Therapeutics, Inc.⁷
• Oct 20, 2025Sold 12,500 shares at $22.08 of Enliven Therapeutics, Inc.⁸
• Sep 26, 2025Sold 4,000 shares at $20.25 of Enliven Therapeutics, Inc.⁹
• Sep 23, 2025Sold 1,500 shares at $20.03 of Enliven Therapeutics, Inc.¹⁰
• Sep 19, 2025Sold 2,130 shares at $20.02 of Enliven Therapeutics, Inc.¹¹
• Sep 19, 2025Sold 4,870 shares at $19.11 of Enliven Therapeutics, Inc.¹¹
• Aug 21, 2025Sold 7,500 shares at $20.01 of Enliven Therapeutics, Inc.¹²
• Aug 19, 2025Sold 5,000 shares at $19.62 of Enliven Therapeutics, Inc.¹²
• Jul 21, 2025Sold 576 shares at $22.90 of Enliven Therapeutics, Inc.¹³
• Jul 21, 2025Sold 11,924 shares at $22.26 of Enliven Therapeutics, Inc.¹³
• Jun 20, 2025Sold 12,500 shares at $21.40 of Enliven Therapeutics, Inc.¹⁴
• Jun 3, 2025Sold 7,500 shares at $20.03 of Enliven Therapeutics, Inc.¹⁵
• May 19, 2025Sold 5,000 shares at $16.31 of Enliven Therapeutics, Inc.¹⁶
• May 2, 2025Sold 2,470 shares at $20.01 of Enliven Therapeutics, Inc.¹⁷
• May 1, 2025Sold 5,030 shares at $20.07 of Enliven Therapeutics, Inc.¹⁷